Barišić, Goran

Link to this page

Authority KeyName Variants
5a08a576-488e-4f89-8c2d-9f524375382d
  • Barišić, Goran (4)
Projects

Author's Bibliography

Markers of Epithelial–Mesenchymal Transition and Mucinous Histology Are Significant Predictors of Disease Severity and Tumor Characteristics in Early-Onset Colorectal Cancer

Djikić Rom, Aleksandra; Dragičević, Sandra; Janković, Radmila; Radojević Skodric, Sanja; Sabljak, Predrag; Marković, Velimir; Stojković, Jovana Rosic; Barišić, Goran; Nikolić, Aleksandra

(MDPI, 2024)

TY  - JOUR
AU  - Djikić Rom, Aleksandra
AU  - Dragičević, Sandra
AU  - Janković, Radmila
AU  - Radojević Skodric, Sanja
AU  - Sabljak, Predrag
AU  - Marković, Velimir
AU  - Stojković, Jovana Rosic
AU  - Barišić, Goran
AU  - Nikolić, Aleksandra
PY  - 2024
UR  - https://www.mdpi.com/2075-4418/14/14/1512
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/2483
AB  - Approximately 20% of patients with colorectal cancer (CRC) are diagnosed with a mucinous subtype of this tumor, have a worse prognosis, and often show resistance to available therapies. Molecules from the mucin family are involved in the regulation of epithelial–mesenchymal transition (EMT), which significantly determines the cancer aggressiveness. This study aimed to examine the diagnostic and prognostic significance of mucinous histology and EMT markers in patients with early-onset CRC and their association with disease severity and tumor characteristics. This study included tumor tissue samples from 106 patients diagnosed with CRC before the age of 45, 53 with mucinous and 53 with non-mucinous tumors. The EMT status was determined by immunohistochemical analysis of E-cadherin and Vimentin in tissue sections. Mucinous tumors had significantly higher Mucin-1 (p < 0.001) and cytoplasmic E-cadherin (p = 0.043) scores; they were significantly less differentiated (p = 0.007), more advanced (p = 0.027), and predominately affected right the colon (p = 0.039) compared to non-mucinous tumors. Epithelial tumors were significantly better differentiated (p = 0.034) and with less prominent tumor budding (p < 0.001) than mesenchymal tumors. Mucin-1 and Vimentin were independent predictors of tumor differentiation (p = 0.006) and budding (p = 0.001), respectively. Mucinous histology and EMT markers are significant predictors of disease severity and tumor characteristics in early-onset colorectal cancer.
PB  - MDPI
T2  - Diagnostics
T1  - Markers of Epithelial–Mesenchymal Transition and Mucinous Histology Are Significant Predictors of Disease Severity and Tumor Characteristics in Early-Onset Colorectal Cancer
IS  - 14
SP  - 1512
VL  - 14
DO  - 10.3390/diagnostics14141512
ER  - 
@article{
author = "Djikić Rom, Aleksandra and Dragičević, Sandra and Janković, Radmila and Radojević Skodric, Sanja and Sabljak, Predrag and Marković, Velimir and Stojković, Jovana Rosic and Barišić, Goran and Nikolić, Aleksandra",
year = "2024",
abstract = "Approximately 20% of patients with colorectal cancer (CRC) are diagnosed with a mucinous subtype of this tumor, have a worse prognosis, and often show resistance to available therapies. Molecules from the mucin family are involved in the regulation of epithelial–mesenchymal transition (EMT), which significantly determines the cancer aggressiveness. This study aimed to examine the diagnostic and prognostic significance of mucinous histology and EMT markers in patients with early-onset CRC and their association with disease severity and tumor characteristics. This study included tumor tissue samples from 106 patients diagnosed with CRC before the age of 45, 53 with mucinous and 53 with non-mucinous tumors. The EMT status was determined by immunohistochemical analysis of E-cadherin and Vimentin in tissue sections. Mucinous tumors had significantly higher Mucin-1 (p < 0.001) and cytoplasmic E-cadherin (p = 0.043) scores; they were significantly less differentiated (p = 0.007), more advanced (p = 0.027), and predominately affected right the colon (p = 0.039) compared to non-mucinous tumors. Epithelial tumors were significantly better differentiated (p = 0.034) and with less prominent tumor budding (p < 0.001) than mesenchymal tumors. Mucin-1 and Vimentin were independent predictors of tumor differentiation (p = 0.006) and budding (p = 0.001), respectively. Mucinous histology and EMT markers are significant predictors of disease severity and tumor characteristics in early-onset colorectal cancer.",
publisher = "MDPI",
journal = "Diagnostics",
title = "Markers of Epithelial–Mesenchymal Transition and Mucinous Histology Are Significant Predictors of Disease Severity and Tumor Characteristics in Early-Onset Colorectal Cancer",
number = "14",
pages = "1512",
volume = "14",
doi = "10.3390/diagnostics14141512"
}
Djikić Rom, A., Dragičević, S., Janković, R., Radojević Skodric, S., Sabljak, P., Marković, V., Stojković, J. R., Barišić, G.,& Nikolić, A.. (2024). Markers of Epithelial–Mesenchymal Transition and Mucinous Histology Are Significant Predictors of Disease Severity and Tumor Characteristics in Early-Onset Colorectal Cancer. in Diagnostics
MDPI., 14(14), 1512.
https://doi.org/10.3390/diagnostics14141512
Djikić Rom A, Dragičević S, Janković R, Radojević Skodric S, Sabljak P, Marković V, Stojković JR, Barišić G, Nikolić A. Markers of Epithelial–Mesenchymal Transition and Mucinous Histology Are Significant Predictors of Disease Severity and Tumor Characteristics in Early-Onset Colorectal Cancer. in Diagnostics. 2024;14(14):1512.
doi:10.3390/diagnostics14141512 .
Djikić Rom, Aleksandra, Dragičević, Sandra, Janković, Radmila, Radojević Skodric, Sanja, Sabljak, Predrag, Marković, Velimir, Stojković, Jovana Rosic, Barišić, Goran, Nikolić, Aleksandra, "Markers of Epithelial–Mesenchymal Transition and Mucinous Histology Are Significant Predictors of Disease Severity and Tumor Characteristics in Early-Onset Colorectal Cancer" in Diagnostics, 14, no. 14 (2024):1512,
https://doi.org/10.3390/diagnostics14141512 . .

Long non-coding RNA NEAT1 cannot be used as a diagnostic and prognostic biomarker in patients with locally advanced rectal cancer

Erić, K.; Rosić, Jovana; Miladinov, Marko; Dragičević, Sandra; Barišić, Goran; Marković, V.; Zeljić, Katarina

(Springer, 2023)

TY  - CONF
AU  - Erić, K.
AU  - Rosić, Jovana
AU  - Miladinov, Marko
AU  - Dragičević, Sandra
AU  - Barišić, Goran
AU  - Marković, V.
AU  - Zeljić, Katarina
PY  - 2023
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/2081
AB  - Background & objectives: The NEAT1 (Nuclear Paraspeckle Assembly Transcript 1) gene encodes a long non-coding RNA that is deregulated in carcinomas of the gastrointestinal tract. Diagnostic and predictive potential of NEAT1 was investigated in patients with locally
advanced rectal cancer.
Methods: The study group consisted of 19 patients with rectal cancer
treated with neoadjuvant chemoradiotherapy (nCRT). RNA was isolated with TRIzol reagent from samples of rectal cancer and noncancerous tissue before and after nCRT. The relative expression level of
NEAT1 normalised to GAPDH was determined by qRT-PCR method.
Results: Expression of NEAT1 did not difer between rectal cancer and
noncancerous tissue before nCRT (p=0.953) and cancer and noncancerous tissue after nCRT (p=0.210). There was no diference in NEAT1
expression between tumour tissue before and after nCRT (p=0.079).
NEAT1 was signifcantly higher in noncancerous tissue before than
after nCRT (p=0.005). Therapy responders (TRG1, TRG2) and nonresponders (TRG3, TRG4) did not difer in NEAT1 levels in tumour
tissue before (p=0.790) and after nCRT (p=0.352). NEAT1 expression
in rectal cancer tissue before nCRT cannot be used as a biomarker to
distinguish responders from non-responders (AUC=0.559, 95%CI=0-
1, p=0.790). Demographic and clinicopathological characteristics were
not associated with NEAT1 expression in rectal cancer tissue.
Conclusion: The obtained results suggest that the long noncoding
RNA NEAT1 cannot be considered as a biomarker with diagnostic
potential or for predicting response to nCRT in patients with rectal
cancer. Validation of the current results in a larger group of patients
with locally advanced rectal cancer is warranted.
PB  - Springer
C3  - Virchows Archiv, 35th European Congress of Pathology  Pathology – a bridge between Science and Medicine, 9 – 13 September
T1  - Long non-coding RNA NEAT1 cannot be used as a diagnostic and prognostic biomarker in patients with locally advanced rectal cancer
EP  - S307
IS  - Supplement 1
SP  - S307
SP  - E-PS-15-011
VL  - 483
UR  - https://hdl.handle.net/21.15107/rcub_imagine_2081
ER  - 
@conference{
author = "Erić, K. and Rosić, Jovana and Miladinov, Marko and Dragičević, Sandra and Barišić, Goran and Marković, V. and Zeljić, Katarina",
year = "2023",
abstract = "Background & objectives: The NEAT1 (Nuclear Paraspeckle Assembly Transcript 1) gene encodes a long non-coding RNA that is deregulated in carcinomas of the gastrointestinal tract. Diagnostic and predictive potential of NEAT1 was investigated in patients with locally
advanced rectal cancer.
Methods: The study group consisted of 19 patients with rectal cancer
treated with neoadjuvant chemoradiotherapy (nCRT). RNA was isolated with TRIzol reagent from samples of rectal cancer and noncancerous tissue before and after nCRT. The relative expression level of
NEAT1 normalised to GAPDH was determined by qRT-PCR method.
Results: Expression of NEAT1 did not difer between rectal cancer and
noncancerous tissue before nCRT (p=0.953) and cancer and noncancerous tissue after nCRT (p=0.210). There was no diference in NEAT1
expression between tumour tissue before and after nCRT (p=0.079).
NEAT1 was signifcantly higher in noncancerous tissue before than
after nCRT (p=0.005). Therapy responders (TRG1, TRG2) and nonresponders (TRG3, TRG4) did not difer in NEAT1 levels in tumour
tissue before (p=0.790) and after nCRT (p=0.352). NEAT1 expression
in rectal cancer tissue before nCRT cannot be used as a biomarker to
distinguish responders from non-responders (AUC=0.559, 95%CI=0-
1, p=0.790). Demographic and clinicopathological characteristics were
not associated with NEAT1 expression in rectal cancer tissue.
Conclusion: The obtained results suggest that the long noncoding
RNA NEAT1 cannot be considered as a biomarker with diagnostic
potential or for predicting response to nCRT in patients with rectal
cancer. Validation of the current results in a larger group of patients
with locally advanced rectal cancer is warranted.",
publisher = "Springer",
journal = "Virchows Archiv, 35th European Congress of Pathology  Pathology – a bridge between Science and Medicine, 9 – 13 September",
title = "Long non-coding RNA NEAT1 cannot be used as a diagnostic and prognostic biomarker in patients with locally advanced rectal cancer",
pages = "S307-S307-E-PS-15-011",
number = "Supplement 1",
volume = "483",
url = "https://hdl.handle.net/21.15107/rcub_imagine_2081"
}
Erić, K., Rosić, J., Miladinov, M., Dragičević, S., Barišić, G., Marković, V.,& Zeljić, K.. (2023). Long non-coding RNA NEAT1 cannot be used as a diagnostic and prognostic biomarker in patients with locally advanced rectal cancer. in Virchows Archiv, 35th European Congress of Pathology  Pathology – a bridge between Science and Medicine, 9 – 13 September
Springer., 483(Supplement 1), S307-S307.
https://hdl.handle.net/21.15107/rcub_imagine_2081
Erić K, Rosić J, Miladinov M, Dragičević S, Barišić G, Marković V, Zeljić K. Long non-coding RNA NEAT1 cannot be used as a diagnostic and prognostic biomarker in patients with locally advanced rectal cancer. in Virchows Archiv, 35th European Congress of Pathology  Pathology – a bridge between Science and Medicine, 9 – 13 September. 2023;483(Supplement 1):S307-S307.
https://hdl.handle.net/21.15107/rcub_imagine_2081 .
Erić, K., Rosić, Jovana, Miladinov, Marko, Dragičević, Sandra, Barišić, Goran, Marković, V., Zeljić, Katarina, "Long non-coding RNA NEAT1 cannot be used as a diagnostic and prognostic biomarker in patients with locally advanced rectal cancer" in Virchows Archiv, 35th European Congress of Pathology  Pathology – a bridge between Science and Medicine, 9 – 13 September, 483, no. Supplement 1 (2023):S307-S307,
https://hdl.handle.net/21.15107/rcub_imagine_2081 .

Expression of long non-coding RNA HOTAIR in rectal cancer as a potential predictor of response to chemoradiotherapy

Erić, Katarina; Miladinov, Marko; Dragičević, Sandra; Rosić, Jovana; Barišić, Goran; Marković, Velimir; Zeljić, Katarina

(Belgrade : Serbian Association on for Cancer Research, 2023)

TY  - CONF
AU  - Erić, Katarina
AU  - Miladinov, Marko
AU  - Dragičević, Sandra
AU  - Rosić, Jovana
AU  - Barišić, Goran
AU  - Marković, Velimir
AU  - Zeljić, Katarina
PY  - 2023
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/2099
AB  - Patients with locally advanced rectal cancer are mainly treated with chemoradiotherapy (CRT) before
surgery. Less than 20% of patients respond completely to neoadjuvant CRT. To avoid unnecessary treatment, biomarkers
are being sought to identi fy pati ents with rectal cancer who do not respond to therapy. The HOX Transcript Anti sense
Intergenic RNA (HOTAIR) is a long non-coding trans-acti ng RNA molecule that is frequently deregulated in cancers of
the digestive tract and plays a role in chemoresistance. The aim of this study was to investigate HOTAIR as a potential
biomarker for predicting treatment response in patients with rectal cancer.
PB  - Belgrade :  Serbian Association on for Cancer Research
C3  - 6th Congress of the Serbian Association for Cancer Research (SDIR)
T1  - Expression of long non-coding RNA HOTAIR in rectal cancer as a potential predictor of response to chemoradiotherapy
EP  - 82
IS  - 1
SP  - 82
UR  - https://hdl.handle.net/21.15107/rcub_imagine_2099
ER  - 
@conference{
author = "Erić, Katarina and Miladinov, Marko and Dragičević, Sandra and Rosić, Jovana and Barišić, Goran and Marković, Velimir and Zeljić, Katarina",
year = "2023",
abstract = "Patients with locally advanced rectal cancer are mainly treated with chemoradiotherapy (CRT) before
surgery. Less than 20% of patients respond completely to neoadjuvant CRT. To avoid unnecessary treatment, biomarkers
are being sought to identi fy pati ents with rectal cancer who do not respond to therapy. The HOX Transcript Anti sense
Intergenic RNA (HOTAIR) is a long non-coding trans-acti ng RNA molecule that is frequently deregulated in cancers of
the digestive tract and plays a role in chemoresistance. The aim of this study was to investigate HOTAIR as a potential
biomarker for predicting treatment response in patients with rectal cancer.",
publisher = "Belgrade :  Serbian Association on for Cancer Research",
journal = "6th Congress of the Serbian Association for Cancer Research (SDIR)",
title = "Expression of long non-coding RNA HOTAIR in rectal cancer as a potential predictor of response to chemoradiotherapy",
pages = "82-82",
number = "1",
url = "https://hdl.handle.net/21.15107/rcub_imagine_2099"
}
Erić, K., Miladinov, M., Dragičević, S., Rosić, J., Barišić, G., Marković, V.,& Zeljić, K.. (2023). Expression of long non-coding RNA HOTAIR in rectal cancer as a potential predictor of response to chemoradiotherapy. in 6th Congress of the Serbian Association for Cancer Research (SDIR)
Belgrade :  Serbian Association on for Cancer Research.(1), 82-82.
https://hdl.handle.net/21.15107/rcub_imagine_2099
Erić K, Miladinov M, Dragičević S, Rosić J, Barišić G, Marković V, Zeljić K. Expression of long non-coding RNA HOTAIR in rectal cancer as a potential predictor of response to chemoradiotherapy. in 6th Congress of the Serbian Association for Cancer Research (SDIR). 2023;(1):82-82.
https://hdl.handle.net/21.15107/rcub_imagine_2099 .
Erić, Katarina, Miladinov, Marko, Dragičević, Sandra, Rosić, Jovana, Barišić, Goran, Marković, Velimir, Zeljić, Katarina, "Expression of long non-coding RNA HOTAIR in rectal cancer as a potential predictor of response to chemoradiotherapy" in 6th Congress of the Serbian Association for Cancer Research (SDIR), no. 1 (2023):82-82,
https://hdl.handle.net/21.15107/rcub_imagine_2099 .

Hirurško lečenje kolorektalnog karcinoma u Srbiji od 2010. do 2014. godine - procena registara više centara

Nikolić, Aleksandra; Krnjajić, Mina; Marković, Velimir; Barišić, Goran; Dimitrijević, Ivan; Krivokapić, Zoran

(Vojnomedicinska akademija - Institut za naučne informacije, Beograd, 2021)

TY  - JOUR
AU  - Nikolić, Aleksandra
AU  - Krnjajić, Mina
AU  - Marković, Velimir
AU  - Barišić, Goran
AU  - Dimitrijević, Ivan
AU  - Krivokapić, Zoran
PY  - 2021
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/1413
AB  - Uvod/Cilj. Hirurški registri i baze podataka su posebno vredni za praćenje karakteristika lečenja i otkrivanje potencijalnih problema kod karcinoma. Za bolesnike sa kolorektalnim karcinomom (KRK) u Srbiji, podaci o primljenoj terapiji, faktorima koji mogu imati uticaja na ishod, odnosno da li je lečenje uspešno i odgovarajuće ili ne, trenutno nisu sistematizovano obrađeni. Cilj rada bio je uspostavljanje baze usaglašenih podataka o hirurškom lečenju KRK u različitim državnim bolnicama širom Srbije i procena ishoda operativnog lečenja obolelih od KRK u periodu od 2010. do 2014. godine. Metode. Istraživanjem su obuhvaćena 52 državna hirurška centra u Srbiji u kojima su sakupljani brojčani podaci o bolesnicima podvrgnutim hirurškoj resekciji KRK. Kreirana je elektronska baza podataka pod nadzorom Prve hirurške klinike Kliničkog centra Srbije, Beograd. Podaci su nezavisno sakupljani korišćenjem posebno sastavljenog standardizovanog upitnika koji je uključio broj operisanih bolesnika, lokalizaciju primarnog tumora, tip hirurške intervencije, urgentnost zahvata i postoperativni mortalitet. Rezultati. Ukupno 22 037 kolorektalnih hirurških procedura izvedeno je u Srbiji u periodu od 2010. do 2014. godine (približno 4 400 godišnje) od čega je bilo 78,5% elektivnih, a 21,5% urgentnih operacija. Najčešći uzrok urgentnih operacija bio je ileus (3 618 bolesnika, 76,4%), dok su manje česti uzroci bili perforacija (899 bolesnika, 18,9%) i krvarenje (216 bolesnika, 4,5%). Postoperativna smrtnost tokom perioda istraživanja, izražena kao procenat svih KRK intervencija, iznosila je prosečno 2,8% sa diskretnom tendencijom rasta. Na kraju studijskog perioda, 127 lekara je bilo obučeno za obavljanje kolonoskopije. Zaključak. Glavni ishod istraživanja bilo je uspostavljanje neophodnih preduslova za multicentrično sakupljanje podataka koji uključuje veliki broj obolelih od KRK. Studija je podržala pretpostavku da je razvoj nacionalne baze podataka hirurškog lečenja KRK dostižan i da može obezbediti značajan uvid u rutinsko hirurško lečenje KRK u Srbiji i doprineti uvećanju resursa za buduća istraživanja.
AB  - Background/Aim. Surgical registries and databases are especially valuable in monitoring the performances in cancer treatment and detecting potential problems. For Serbian patients with colorectal cancer (CRC), data regarding the treatment received, the factors that may impact the outcome, and whether or not treatment is successful and appropriate are not currently captured. The aim of this study was to establish a collection of a consensus dataset capturing surgical treatment of CRC at multiple public hospitals across Serbia and estimate outcome in CRC patients subjected to surgical treatment in the period 2010-2014. Methods. The study encompassed all 52 public CRC surgical units in Serbia. Numerical data on all patients who underwent operative CRC resection were included. An electronic database was created and overseen by the First Surgical Clinic of the Clinical Center of Serbia, Belgrade. Data were collected independently using a specifically designed standardized questionnaire, including the number of operated patients, localization of the primary tumor, type of surgical intervention, type and urgency of surgical intervention, and postoperative mortality. Results. A total number of 22,037 colorectal surgical procedures was performed in Serbia in the period 2010-2014 (approximately 4,400 per year). It was shown that 78.5% of the total number of procedures were elective and 21.5% were emergency. The most common cause of emergency surgeries was ileus (3,618 cases, 76.4%), while the less common causes were perforation (899 cases, 18.9%) and bleeding (216 cases, 4.5%). Postoperative mortality during the study period expressed as a percentage of all interventions for CRC was 2.8% on average with a slight increasing tendency. At the end of the study period, 127 doctors were educated for performing colonoscopy. Conclusion. The main outcome of this study was the establishment of the necessary preconditions for the multicenter data collection involving large numbers of CRC patients. The study supported the premise that the development of the national database for surgical treatment of CRC is achievable and could provide valuable insight into the routine surgical management of CRC in Serbia, creating a significant resource for further research.
PB  - Vojnomedicinska akademija - Institut za naučne informacije, Beograd
T2  - Vojnosanitetski pregled
T1  - Hirurško lečenje kolorektalnog karcinoma u Srbiji od 2010. do 2014. godine - procena registara više centara
T1  - Colorectal cancer surgery in Serbia 2010-2014: An evaluation of a multicenter registry
EP  - 444
IS  - 4
SP  - 440
VL  - 78
DO  - 10.2298/VSP190610080N
ER  - 
@article{
author = "Nikolić, Aleksandra and Krnjajić, Mina and Marković, Velimir and Barišić, Goran and Dimitrijević, Ivan and Krivokapić, Zoran",
year = "2021",
abstract = "Uvod/Cilj. Hirurški registri i baze podataka su posebno vredni za praćenje karakteristika lečenja i otkrivanje potencijalnih problema kod karcinoma. Za bolesnike sa kolorektalnim karcinomom (KRK) u Srbiji, podaci o primljenoj terapiji, faktorima koji mogu imati uticaja na ishod, odnosno da li je lečenje uspešno i odgovarajuće ili ne, trenutno nisu sistematizovano obrađeni. Cilj rada bio je uspostavljanje baze usaglašenih podataka o hirurškom lečenju KRK u različitim državnim bolnicama širom Srbije i procena ishoda operativnog lečenja obolelih od KRK u periodu od 2010. do 2014. godine. Metode. Istraživanjem su obuhvaćena 52 državna hirurška centra u Srbiji u kojima su sakupljani brojčani podaci o bolesnicima podvrgnutim hirurškoj resekciji KRK. Kreirana je elektronska baza podataka pod nadzorom Prve hirurške klinike Kliničkog centra Srbije, Beograd. Podaci su nezavisno sakupljani korišćenjem posebno sastavljenog standardizovanog upitnika koji je uključio broj operisanih bolesnika, lokalizaciju primarnog tumora, tip hirurške intervencije, urgentnost zahvata i postoperativni mortalitet. Rezultati. Ukupno 22 037 kolorektalnih hirurških procedura izvedeno je u Srbiji u periodu od 2010. do 2014. godine (približno 4 400 godišnje) od čega je bilo 78,5% elektivnih, a 21,5% urgentnih operacija. Najčešći uzrok urgentnih operacija bio je ileus (3 618 bolesnika, 76,4%), dok su manje česti uzroci bili perforacija (899 bolesnika, 18,9%) i krvarenje (216 bolesnika, 4,5%). Postoperativna smrtnost tokom perioda istraživanja, izražena kao procenat svih KRK intervencija, iznosila je prosečno 2,8% sa diskretnom tendencijom rasta. Na kraju studijskog perioda, 127 lekara je bilo obučeno za obavljanje kolonoskopije. Zaključak. Glavni ishod istraživanja bilo je uspostavljanje neophodnih preduslova za multicentrično sakupljanje podataka koji uključuje veliki broj obolelih od KRK. Studija je podržala pretpostavku da je razvoj nacionalne baze podataka hirurškog lečenja KRK dostižan i da može obezbediti značajan uvid u rutinsko hirurško lečenje KRK u Srbiji i doprineti uvećanju resursa za buduća istraživanja., Background/Aim. Surgical registries and databases are especially valuable in monitoring the performances in cancer treatment and detecting potential problems. For Serbian patients with colorectal cancer (CRC), data regarding the treatment received, the factors that may impact the outcome, and whether or not treatment is successful and appropriate are not currently captured. The aim of this study was to establish a collection of a consensus dataset capturing surgical treatment of CRC at multiple public hospitals across Serbia and estimate outcome in CRC patients subjected to surgical treatment in the period 2010-2014. Methods. The study encompassed all 52 public CRC surgical units in Serbia. Numerical data on all patients who underwent operative CRC resection were included. An electronic database was created and overseen by the First Surgical Clinic of the Clinical Center of Serbia, Belgrade. Data were collected independently using a specifically designed standardized questionnaire, including the number of operated patients, localization of the primary tumor, type of surgical intervention, type and urgency of surgical intervention, and postoperative mortality. Results. A total number of 22,037 colorectal surgical procedures was performed in Serbia in the period 2010-2014 (approximately 4,400 per year). It was shown that 78.5% of the total number of procedures were elective and 21.5% were emergency. The most common cause of emergency surgeries was ileus (3,618 cases, 76.4%), while the less common causes were perforation (899 cases, 18.9%) and bleeding (216 cases, 4.5%). Postoperative mortality during the study period expressed as a percentage of all interventions for CRC was 2.8% on average with a slight increasing tendency. At the end of the study period, 127 doctors were educated for performing colonoscopy. Conclusion. The main outcome of this study was the establishment of the necessary preconditions for the multicenter data collection involving large numbers of CRC patients. The study supported the premise that the development of the national database for surgical treatment of CRC is achievable and could provide valuable insight into the routine surgical management of CRC in Serbia, creating a significant resource for further research.",
publisher = "Vojnomedicinska akademija - Institut za naučne informacije, Beograd",
journal = "Vojnosanitetski pregled",
title = "Hirurško lečenje kolorektalnog karcinoma u Srbiji od 2010. do 2014. godine - procena registara više centara, Colorectal cancer surgery in Serbia 2010-2014: An evaluation of a multicenter registry",
pages = "444-440",
number = "4",
volume = "78",
doi = "10.2298/VSP190610080N"
}
Nikolić, A., Krnjajić, M., Marković, V., Barišić, G., Dimitrijević, I.,& Krivokapić, Z.. (2021). Hirurško lečenje kolorektalnog karcinoma u Srbiji od 2010. do 2014. godine - procena registara više centara. in Vojnosanitetski pregled
Vojnomedicinska akademija - Institut za naučne informacije, Beograd., 78(4), 440-444.
https://doi.org/10.2298/VSP190610080N
Nikolić A, Krnjajić M, Marković V, Barišić G, Dimitrijević I, Krivokapić Z. Hirurško lečenje kolorektalnog karcinoma u Srbiji od 2010. do 2014. godine - procena registara više centara. in Vojnosanitetski pregled. 2021;78(4):440-444.
doi:10.2298/VSP190610080N .
Nikolić, Aleksandra, Krnjajić, Mina, Marković, Velimir, Barišić, Goran, Dimitrijević, Ivan, Krivokapić, Zoran, "Hirurško lečenje kolorektalnog karcinoma u Srbiji od 2010. do 2014. godine - procena registara više centara" in Vojnosanitetski pregled, 78, no. 4 (2021):440-444,
https://doi.org/10.2298/VSP190610080N . .
1